Avricore Health (AVCRF) Revenue Growth (3y) (2012 - 2026)
Avricore Health (AVCRF) Revenue Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 3.92% |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | 1.95% |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 8.84% |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 2.24% |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | 5.42% |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | 42.30% |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | -0.48% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | 1.51% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 9.18% |
| 10 | Avricore Health | 3.04 Mn | 3.01 Mn | -6,202.70 | -57.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -57.18% |
| Dec 31, 2025 | -67.82% |
| Sep 30, 2025 | -60.34% |
| Jun 30, 2025 | -46.88% |
| Mar 31, 2025 | 107.75% |
| Sep 30, 2024 | 246.14% |
| Jun 30, 2024 | 635.42% |
| Mar 31, 2024 | 418.52% |
| Dec 31, 2023 | 443.42% |
| Sep 30, 2023 | 389.47% |
| Jun 30, 2023 | 305.54% |
| Mar 31, 2023 | 320.64% |
| Dec 31, 2022 | 386.42% |
| Sep 30, 2022 | 273.85% |
| Jun 30, 2022 | 107.37% |
| Mar 31, 2022 | 94.45% |
| Dec 31, 2021 | 28.55% |
| Sep 30, 2021 | 197.67% |
| Jun 30, 2021 | -68.11% |
| Dec 31, 2020 | -62.62% |